Activin and Inhibin

GSK8573 is an inactive control compound for GSK2801 (acetyl-lysine competitive inhibitor of BAZ2A and BAZ2B bromodomains). GSK8573 has binding activity to BRD9 with a K d value of 1.04 μM and is inactive against BAZ2A/B and other bromodomain

GSK8573 is an inactive control compound for GSK2801 (acetyl-lysine competitive inhibitor of BAZ2A and BAZ2B bromodomains). GSK8573 has binding activity to BRD9 with a K d value of 1.04 μM and is inactive against BAZ2A/B and other bromodomain

GSK8573 is an inactive control compound for GSK2801 (acetyl-lysine competitive inhibitor of BAZ2A and BAZ2B bromodomains). GSK8573 has binding activity to BRD9 with a K d value of 1.04 μM and is inactive against BAZ2A/B and other bromodomain

GSK864 is an isocitrate dehydrogenase 1 ( IDH1 ) mutant inhibitor: inhibits IDH1 mutants R132C, R132H, and R132G with IC 50 values of 8.8, 15.2 and 16.6 nM.In VitroGSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with

GSK864 is an isocitrate dehydrogenase 1 ( IDH1 ) mutant inhibitor: inhibits IDH1 mutants R132C, R132H, and R132G with IC 50 values of 8.8, 15.2 and 16.6 nM.In VitroGSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with

GSK864 is an isocitrate dehydrogenase 1 ( IDH1 ) mutant inhibitor: inhibits IDH1 mutants R132C, R132H, and R132G with IC 50 values of 8.8, 15.2 and 16.6 nM.In VitroGSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with

GSK864 is an isocitrate dehydrogenase 1 ( IDH1 ) mutant inhibitor: inhibits IDH1 mutants R132C, R132H, and R132G with IC 50 values of 8.8, 15.2 and 16.6 nM.In VitroGSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with

GSK864 is an isocitrate dehydrogenase 1 ( IDH1 ) mutant inhibitor: inhibits IDH1 mutants R132C, R132H, and R132G with IC 50 values of 8.8, 15.2 and 16.6 nM.In VitroGSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with

GSK864 is an isocitrate dehydrogenase 1 ( IDH1 ) mutant inhibitor: inhibits IDH1 mutants R132C, R132H, and R132G with IC 50 values of 8.8, 15.2 and 16.6 nM.In VitroGSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with

GSK864 is an isocitrate dehydrogenase 1 ( IDH1 ) mutant inhibitor: inhibits IDH1 mutants R132C, R132H, and R132G with IC 50 values of 8.8, 15.2 and 16.6 nM.In VitroGSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with

GSK8814 is a potent, selective, and ATAD2/2B bromodomain chemical probe and inhibitor, with a binding constant pK d =8.1 and a pK i =8.9 in BROMOscan. GSK8814 binds to ATAD2 and BRD4 BD1 with pIC 50 s of 7.3 and 4.6, respectively. GSK8814 shows

GSK8814 is a potent, selective, and ATAD2/2B bromodomain chemical probe and inhibitor, with a binding constant pK d =8.1 and a pK i =8.9 in BROMOscan. GSK8814 binds to ATAD2 and BRD4 BD1 with pIC 50 s of 7.3 and 4.6, respectively. GSK8814 shows